sodium citrate, anhydrous has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghafoor, F; Iqbal, IA; Naz, S | 1 |
| Daly, RL; Dhutia, AJ; Ecob, R; Howgego, KE; Judge, HM; Mehra, S; Morton, AC; Storey, RF; Sumaya, W | 1 |
2 other study(ies) available for sodium citrate, anhydrous and Acute Coronary Syndrome
| Article | Year |
|---|---|
Effect of collection tube type and freeze-thaw cycles on myeloperoxidase concentrations in blood samples of acute coronary syndrome patients.
Topics: Acute Coronary Syndrome; Adult; Aged; Anticoagulants; Biomarkers; Centrifugation; Citrates; Cryopreservation; Edetic Acid; Female; Heparin; Humans; Male; Middle Aged; Peroxidase; Phlebotomy; Sodium Citrate; Temperature; Tertiary Care Centers; Time Factors | 2017 |
Hirudin anticoagulation allows more rapid determination of P2Y₁₂ inhibition by the VerifyNow P2Y12 assay.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Antithrombins; Area Under Curve; Cations; Citrates; Clopidogrel; Coronary Angiography; Female; Hematologic Tests; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Function Tests; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12; Sodium Citrate; Thiophenes; Ticlopidine; Treatment Outcome | 2013 |